Skip to main content

Depakote News

FDA Medwatch Alert: Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine Headaches

Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their generics ISSUE: FDA is advising health care...

FDA Medwatch Alert: Valproate Products: Drug Safety Communication - Risk of Impaired Cognitive Development in Children Exposed In Utero (During Pregnancy)

Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their generics ISSUE: FDA notified healthcare professionals...

FDA Medwatch Alert: Antiepileptic Drugs

[UPDATE 05/05/2009] FDA notified healthcare professionals that it approved updated labeling for antiepileptic drugs used to treat epilepsy, psychiatric disorders, and other conditions (e.g., migraine...

FDA Medwatch Alert: Depakote / Depakene / Depacon (divalproex sodium / valproic acid / valproate sodium)

FDA and Abbott strengthened the CONTRAINDICATIONS, WARNINGS and PRECAUTIONS sections of the label for Depakote Tablets, Depakote ER Tablets, Depakote Sprinkle Capsules, Depakene Capsules and Syrup...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Bipolar Disorder, Mania, Seizures, Epilepsy, Migraine Prevention, Migraine Prophylaxis

Depakote patient information at Drugs.com